Literature DB >> 20119726

[Successful therapy with etanercept in relapsing polychondritis].

C Schräder1, J Lohmann.   

Abstract

Relapsing polychondritis is a rare autoimmune disease associated with inflammation and destruction of cartilage and connective tissue.We report on a patient with a severe form of this disease that had a progressive and complicated course despite administration of a number of disease-modifying anti-rheumatic drugs.Finally, therapy with the TNF-alpha-antagonist etanercept was initiated, which led to a considerable decrease in disease activity. This case is further evidence for the efficiency of TNF-alpha-antagonists in relapsing polychondritis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20119726     DOI: 10.1007/s00393-009-0601-9

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  11 in total

1.  Treatment of relapsing polychondritis with a TNF antagonist.

Authors:  John D Carter
Journal:  J Rheumatol       Date:  2005-07       Impact factor: 4.666

Review 2.  Relapsing polychondritis.

Authors:  Ronald P Rapini; Noranna B Warner
Journal:  Clin Dermatol       Date:  2006 Nov-Dec       Impact factor: 3.541

3.  Leflunomide for relapsing polychondritis: successful longterm treatment.

Authors:  Richard P Handler
Journal:  J Rheumatol       Date:  2006-09       Impact factor: 4.666

Review 4.  Autologous stem cell transplantation of treatment-resistant systemic vasculitis--a single center experience and review of the literature.

Authors:  I Kötter; T Daikeler; C Amberger; A Tyndall; L Kanz
Journal:  Clin Nephrol       Date:  2005-12       Impact factor: 0.975

5.  Complete remission in refractory relapsing polychondritis with intravenous immunoglobulins.

Authors:  B Terrier; A Aouba; B Bienvenu; C Bloch-Queyrat; E Delair; J Mallet; A Mahr; L Guillevin
Journal:  Clin Exp Rheumatol       Date:  2008 Jan-Feb       Impact factor: 4.473

6.  Sustained response to etanercept after failing infliximab, in a patient with relapsing polychondritis with tracheomalacia.

Authors:  P Subrahmanyam; C Balakrishnan; B Dasgupta
Journal:  Scand J Rheumatol       Date:  2008 May-Jun       Impact factor: 3.641

7.  Successful treatment of relapsing polychondritis with mycophenolate mofetil.

Authors:  Gary Goldenberg; Omar P Sangueza; Joseph L Jorizzo
Journal:  J Dermatolog Treat       Date:  2006       Impact factor: 3.359

8.  Relapsing polychondritis--report of ten cases.

Authors:  J M Damiani; H L Levine
Journal:  Laryngoscope       Date:  1979-06       Impact factor: 3.325

9.  The development of trigeminal neuralgia related to auricular chondritis in a patient with rheumatoid arthritis-relapsing polychondritis and its treatment with etanercept. Description of the first case.

Authors:  O N Pamuk; F Harmandar; N Cakir
Journal:  Clin Exp Rheumatol       Date:  2009 Jan-Feb       Impact factor: 4.473

Review 10.  A systematic review of the off-label use of biological therapies in systemic autoimmune diseases.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Sandra Muñoz; María-José Soto
Journal:  Medicine (Baltimore)       Date:  2008-11       Impact factor: 1.889

View more
  2 in total

Review 1.  Relapsing polychondritis: a review.

Authors:  Aman Sharma; Karthik Gnanapandithan; Kusum Sharma; Susmita Sharma
Journal:  Clin Rheumatol       Date:  2013-07-26       Impact factor: 2.980

2.  Central airway obstruction: is it time to move forward?

Authors:  Fernando Guedes; Mariana V Branquinho; Ana C Sousa; Rui D Alvites; António Bugalho; Ana Colette Maurício
Journal:  BMC Pulm Med       Date:  2022-02-19       Impact factor: 3.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.